OT Interventional Cardiology

Oxford University Press
  • 2. Auflage
  • |
  • erscheint ca. am 5. Juli 2018
  • Buch
  • |
  • Hardcover
  • |
  • 808 Seiten
978-0-19-875415-2 (ISBN)
This is the definitive text spanning the whole spectrum of Interventional Cardiology, including the management of patients with coronary artery disease. It has been updated to include new sections, covering the major developments in techniques within the field from the previous edition.
2nd edition
  • Englisch
  • Oxford
  • |
  • Großbritannien
  • Für Beruf und Forschung
  • Überarbeitete Ausgabe
  • Höhe: 276 mm
  • |
  • Breite: 219 mm
978-0-19-875415-2 (9780198754152)
0198754159 (0198754159)
weitere Ausgaben werden ermittelt
Simon Redwood trained in cardiology at The Royal London Hospital, The Royal Free Hospital and St. George's Hospital, London. Interventional training was obtained at The Washington Cardiology Center, Washington, DC and Guy's and St. Thomas' Hospitals. He obtained Fellowship of the American College of Cardiology in 2001 and became a Fellow of the Royal College of Physicians in 2003 and Fellow of the Society of Angiography and Interventions in 2004. Dr Redwood is Reader/ Consultant Interventional Cardiologist and Director of the Cardiac Catheter labs at St. Thomas', one of the highest volume catheter lab suites in the UK. He is also a Council Member and Treasurer of the British Cardiovascular Intervention Society. He is trained in all aspects of adult interventional cardiology including intravascular ultrasound, physiological lesion assessment using pressure-sensor tipped wires, stent implantation, rotational atherectomy, and laser angioplasty including the laserwire for chronic total occlusions.; Nick Curzen is a consultant cardiologist with a special interest in coronary intervention at Southampton University Hospitals NHS Trust and Honorary Senior Lecturer at Southampton University Medical School. He qualified from Southampton with Honours in 1987 and obtained MRCP in 1990. In 1996 he was awarded his PhD from Imperial College, London, for a thesis involving vascular pharmacology and molecular biology. His clinical training was at Southampton University, Royal Bournemouth, Royal Brompton, London Chest and St Bartholomews hospitals. He became a consultant interventional cardiologist at Manchester Royal Infirmary in 1999 and moved to Wessex Cardiothoracic Centre, Southampton in January 2004.; Adrian Banning is consultant cardiologist at the John Radcliffe University Hospital, Oxford, and currently holds the post of President of the British Cardiovascular Intervention Society (BCIS). He was the Clinical Lead for cardiac medicine, and subsequently the Divisional Director for Cardiology, Cardiothoracic, and Vascular Surgery for the John Radcliffe, and has been the leading investigator for multiple practice-changing trials, including Syntax, Excel, and Horizons. He qualified from St George's Hospital, London in 1987, and obtained Fellowship of the European Society of Cardiology in 2001, followed by Fellowship of the Royal College of Physicians in 2003. He was Assistant Editor to the journal Heart for six years, and has published over 190 peer reviewed papers.
Background and basics; 1 Robert Henderson, Richard Varcoe: The epidemiology and pathophysiology of coronary artery disease; 2 Toby Rogers, Kenneth Kent, and Augusto D. Pichard: The history of interventional cardiology; 3 Peter F. Ludman: Risk assessment and analysis of outcomes; 4 David H. Roberts: Vascular access: femoral versus radial; 5 Gurbir Bhatia, James Nolan: Radiation and percutaneous coronary intervention; 6 Rod Stables: The 'golden rules' of percutaneous coronary intervention; 7 Kevin O'Gallagher, Jonathan Byrne, and Philip MacCarthy: Routine management after percutaneous coronary intervention; 8 Ayman Al-Saleh and Sanjit Jolly: Trial design and interpretation: statistics in PCI; Percutaneous coronary intervention-related imaging; 9 David Adlam, Annette Maznyczka, and Bernard Prendergast: Angiography: indications and limitations; 10 Olivier Muller, Stephane Fournier, Bernard De Bruyne: Coronary physiology in clinical practice; 11 Hiromasa Otake, Yasuhiro Honda, and Peter J. Fitzgerald: The role of intravascular ultrasound in percutaneous coronary intervention; 12 Ravinay Bhindi and Keith M. Channon: Optical Coherence Tomography in Percutaneous Coronary Intervention; 13 A. Coenen, L.E. Swart, R.P.J. Budde, and K. Nieman: Coronary computed tomography for the interventionalist; 14 Theodoros D. Karamitsos and Stefan Neubauer: Cardiovascular magnetic resonance; Percutaneous coronary intervention by clinical syndrome; 15 Vasim Farooq and Patrick W. Serruys: Stable coronary artery disease: medical therapy versus percutaneous coronary intervention versus surgery; 16 Bashir Alaour, Michael Mahmoudi and Nick Curzen: Percutaneous coronary intervention in non-ST elevation acute coronary syndrome; 17 Zulfiquar Adam and Mark A. de Belder: Primary percutaneous coronary intervention for ST elevation myocardial infarction; 18 Divaka Perera and Natalia Briceno: Percutaneous coronary intervention in patients with impaired left ventricular function; Percutaneous coronary intervention by lesion and patient subsets; 19 Yves Louvard, Philippe Garot, Thomas Hovasse, Bernard Chevalier, and Thierry Lefevre: Coronary bifurcation stenting: state of the art; 20 Michael Mahmoudi, Nick Curzen, Christine Hughes, Bruno Farah, and Jean Fajadet: Percutaneous coronary intervention for unprotected and protected left main stem disease; 21 Colm G. Hanratty, James C. Spratt, Simon J. Walsh: Chronic total occlusions; 22 George Kassimis and Adrian P. Banning: Revascularisation in patients with diabetes mellitus; 23 Marko Noc and Peter Radsel: Out of Hospital Arrest: Role of PCI; Adjunctive drug therapies in percutaneous coronary intervention; 24 Vikram Khanna, Tony Gershlick and Nick Curzen: Current status of oralantiplatelet therapies; 25 Tim Lockie: Current status of GP IIb/IIIa inhibitors; 26 Stefanie Schupke, Steffen Massberg, and Adnan Kastrati: The role of bivalirudin in percutaneous coronary intervention; 27 Simon J. Corbett and Nick Curzen: Optimal medical therapy in percutaneous coronary intervention patients: statins and ACE inhibitors as disease-modifying agents; 28 Mikhail S. Dzeshka, Richard A. Brown, and Gregory Y.H. Lip: New Oral Anti-Coagulants (NOACs) and other Adjunctive Therapies; Complications of percutaneous coronary intervention; 29 Peter A. McCullough: Contrast-induced acute kidney injury; 30 Jaya Chandrasekhar, Adriano Caixeta, Philippe Genereux, George Dangas, and Roxana Mehran: In-stent restenosis in the drug-eluting stent era; 31 Nikesh Malik, Amerjeet Banning, and Tony Gershlick: Stent thrombosis; 32 Adam de Belder: Stent loss and retrieval; 33 Mark Gunning and Chee Wah Khoo: Coronary artery perforation; Special devices in percutaneous coronary intervention; 34 Adam de Belder, Martyn Thomas, and Emanuele Barbato: Rotational atherectomy; 35 Peter O'Kane and Simon Redwood: Laser; 36 Giovanni Luigi De Maria and Adrian P. Banning: Saphenous Vein Graft PCI, Distal Protection and no-reflow; 37 Adam J. Brown and Nick E. J. West: Bioresorbable Vascular Scaffolds; 38 Corrado Tamburino, Claudia Ina Tamburino and Sebastiano Imme: Access Sites and the TAVI Procedure; 39 Mohamed Abdel-Wahab and John Jose: Selection of TAVI Prostheses; 40 Muhammed Zeeshan Khawaja and Simon Redwood: Co-existent Coronary Artery Disease in Patients Undergoing TAVI: When and When Not to Treat; 41 Michael Bellamy and Christopher Baker: Transcatheter Mitral Valve Repair; 42 Ricardo Boix Garibo, Mohsin Uzzaman, Michael Ghosh-Dastidar, and Vinayak Bapat: Transcatheter Mitral Valve Replacement; Other Non-coronary percutaneous interventions; 43 Patrick A. Calvert, Bushra S. Rana, Roland Hilling-Smith, and David Hildick-Smith: Percutaneous device closure of atrial septal defect and patent foramen ovale; 44 Alec Vahanian, Dominique Himbert, Eric Brochet, Gregory Ducrocq, and Bernard Iung: Mitral balloon valvuloplasty; 45 Charles Knight, Saidi Mohiddin, and Constantinos O'Mahony: Alcohol septal ablation for obstructive hypertrophic cardiomyopathy; 46 Iqbal Malik and Mohamed Hamady: Carotid artery stenting; 47 Tim Betts: Left Atrial Appendage Occlusion; The Future; 48 Kenneth Chan, Manish Saxena, and Melvin D. Lobo: Novel Therapies for Hypertension; 49 Giora Weisz: Robotic PCI; 50 Fizzah Choudry and Anthony Mathur: Stem Cell Therapy and Delivery
Review from previous edition The scope of the book and the authorship is vast, and there is no topic which has not been covered in detail and for this the editors should be congratulated. This book is a must for every interventional department as a useful reference for the trainee, trained cardiologist, and the cathlab team. * Dr Sarah Clarke, Consultant Cardiologist, in Cardiology News *

Noch nicht erschienen

172,89 €
inkl. 7% MwSt.

Abholung vor Ort? Sehr gerne!
Unsere Web-Seiten verwenden Cookies. Mit der Nutzung dieser Web-Seiten erklären Sie sich damit einverstanden. Mehr Informationen finden Sie in unserem Datenschutzhinweis. Ok